Mantec, Robert .
HRN: 22-83-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2023
CEFTRIAXONE 1G (VIAL)
03/23/2023
03/30/2023
INTRAVENOUS
700 Mg
OD
T/C TBI
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes